|
|
Volumn 15, Issue 10, 2016, Pages 663-665
|
|
The cancer vaccine resurgence
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATEZOLIZUMAB;
CANCER VACCINE;
CHIMERIC ANTIGEN RECEPTOR;
IPILIMUMAB;
MAJOR HISTOCOMPATIBILITY ANTIGEN;
MELANOMA ANTIGEN 3;
MESSENGER RNA;
MUCIN 1;
NANOPARTICLE;
RINDOPEPIMUT;
TECEMOTIDE;
TUMOR ANTIGEN;
ANTIGEN EXPRESSION;
ANTIGEN PRESENTING CELL;
AUTOIMMUNITY;
BREAST CANCER;
CANCER IMMUNIZATION;
DNA SEQUENCE;
DRUG INDUSTRY;
GLIOBLASTOMA;
HUMAN;
IMMUNOGENICITY;
IN VIVO STUDY;
MELANOMA;
NON SMALL CELL LUNG CANCER;
OVARY CANCER;
PANCREAS CANCER;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RNA SEQUENCE;
SHORT SURVEY;
T LYMPHOCYTE;
ANIMAL;
GENETICS;
NEOPLASMS;
PROCEDURES;
TRENDS;
VACCINATION;
ANIMALS;
CANCER VACCINES;
DRUG INDUSTRY;
HUMANS;
NEOPLASMS;
VACCINATION;
|
|
EID: 84989271235
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd.2016.201 Document Type: Short Survey |
|
Times cited : (44)
|
|
References (0)
|
